Detalhe da pesquisa
1.
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study).
Int J Gynecol Cancer
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724237
2.
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
Cancer Immunol Immunother
; 72(2): 475-491, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960332
3.
Current "state of the art" on dendritic cell-based cancer vaccines in melanoma.
Curr Opin Oncol
; 35(2): 87-93, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721893
4.
The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer.
Int J Mol Sci
; 21(15)2020 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32751388
5.
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.
BMC Cancer
; 19(1): 506, 2019 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138229
6.
Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity.
Int J Mol Sci
; 20(14)2019 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340438
7.
In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer.
Int J Mol Sci
; 17(9)2016 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27618037
8.
Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy.
Cancer Immunol Immunother
; 63(6): 545-57, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658839
9.
Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations.
J Transl Med
; 12: 179, 2014 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957270
10.
Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma.
J Immunother Cancer
; 12(1)2024 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212127
11.
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade.
Clin Transl Med
; 14(5): e1655, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711203
12.
Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives.
Front Immunol
; 14: 1183641, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37275902
13.
Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113895
14.
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.
Oncoimmunology
; 11(1): 2096363, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35800158
15.
Dendritic cell therapy for oncology roundtable conference.
J Immune Based Ther Vaccines
; 9(1): 1, 2011 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21226916
16.
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
Cancers (Basel)
; 13(9)2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922556
17.
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
Cancers (Basel)
; 13(16)2021 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439142
18.
Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells.
Front Immunol
; 12: 733506, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34777344
19.
Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Clin Cancer Res
; 15(10): 3366-75, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19417017
20.
Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial.
Vaccines (Basel)
; 8(4)2020 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33182610